Business Area Labtech

The Labtech business area offers the subsidiaries products, solutions and a broad range of services in diagnostics, biomedical research and laboratory analysis. Customers include research laboratories, university hospitals, pharmaceutical  companies and players in the food industry, primarily in the Nordic countries, as well as in Central and Eastern Europe.

Innovation helps us to develop our working methods

Torill Wertebach and Catherine Pettersen, Marknad Bergman Diagnostika AS Norge

The world is changing and evolving rapidly, both technically and digitally. During the covid-19 pandemic, it has become even more important to keep in touch digitally with customers and suppliers. That is why we have started to use the Smarketing method, which effectively connects competencies in sales and marketing. Innovation is one of our core values and should permeate everything from organizational and product development to new ways of reaching customers.


Key figures 2020

Net sales: 3,212 SEKm
Employees: 601
Share of net sales: 61 %

The Labtech business area offers products, solutions and services in diagnostics, as well as in biomedical research and laboratory analysis. The subsidiaries have well developed local sales and service organisations to be able to work closely with customers and suppliers.

Labtech’s offering mainly targets everything for diagnostics and research laboratories in the Nordic countries and the rest of Europe. The products, which are used to diagnose diseases or to conduct research, include instruments and equipment, as well as consumables and reagents for the installed equipment. Laboratory technology is a knowledge-intensive area and customers are therefore offered services such as support, maintenance, advice and training to ensure efficient use of the equipment.

Market trend in 2020

Growth in the Labtech business area has been largely driven by the COVID-19 pandemic, as other treatments have been reduced to a minimum in hospitals. During the year, extensive COVID-19 testing was conducted in all markets and our diagnostic companies were able to offer both instruments and large volumes of certified tests from several different manufacturers. We have mainly sold PCR tests, which are used to detect ongoing infection. For our companies, it has been a competitive advantage to be able to offer solutions from several suppliers in order to secure customers' access to products.

In connection with the treatment of COVID-19 patients, the hospitals' intensive care units, ICU, have had a very high consumption of various tests to obtain information about the patient's status. Our product area Blood Gas Analysis, which provides important information about the patient's lung function, had high growth during the first half of the year, both on new instruments but above all on reagent consumption. During the summer, fewer COVID-19 patients were treated at ICU, but in the autumn a second wave arose and demand increased again.

During the pandemic, many customers have deviated from normal purchasing routines and instead made purchases via direct procurement to gain quick access to products. The extensive sales of instruments to the diagnostic laboratories during the year contribute to a larger installed base, which in turn opens up for increased sales of reagents for many years to come.

Demand was strong within the research companies during the first months of the year, until the outbreak of COVID-19, when the market situation changed radically. Initially, the activity of the academic customers decreased and in several countries the universities were closed due to restrictions, but during the second half of the year we experienced a recovery. Many research teams that work with various COVID-related projects have received increased funding for their research from both private and government actors, which has driven demand for several of our products. Despite a strong focus on virus research, we also see a positive sales trend in other research areas and to the pharmaceutical companies. However, sales to veterinary and food customers have been weaker. Sales of our advanced materials analysis materials to academic clients in China and the US were also relatively weak during the year.

Labtech´s Product Segment

  • Haematology
  • Pathology
  • POC (point-of-care diagnostics)
  • Cell biology
  • Genetics
  • Microbiology
  • Virology
  • Molecular biology
  • Clinical chemistry
  • Immunology
  • Consumables
  • Analytical instruments

Long-term responsibility paves the way for new business

Franco Martinez, Sales Manager Euroclone Italy

For me, AddLife’s core value “simplicity” is a way of thinking. Simplicity creates clarity and helps us to focus on our core business. I always search for the solution that gives the greatest advantage for the least possible effort. Daily life here at one of AddLife’s subsidiaries is also characterised by simple, quick decision-making processes with digital solutions. The distance between idea and action is never far – where simplicity is often identical to the shortest path to success.



Sales of laboratory instruments and service services to research, industry, universities and colleges

Geographical market: Sweden, Denmark, Norway

Segment: Instruments and microscopy

Customer examples: Astra Zeneca, Lunds University, Karolinska Institute

Amount of employees: 16

Sales of analytical instruments and services for surface science research and development in academia and industry

Geographical market: World Wide

Segment: Advanced material development in academia and industry

Customer examples: P&G, IBM, Apple, BASF, Stanford University, Harvard University, Peking University

Amount of employees: 60

Sales of laboratory and diagnostic reagents

Geographical market: The Benelux

Segment: Life sciences, R&D, diagnostics, biotechnology, pharma

Customer examples: Academic research institutes as well as commercial companies

Amount of employees: 37

Wide assortment of products and services for the laboratory.

Geographical market: Central- and Eastern Europe

Segment: In vitro diagnostics, veterinary and food diagnostics, research reagents & instruments, Biomedica Immunoassays, Services

Customer examples: Private and Public Hospitals / Reference Centers / Private Laboratories / CROs / Research Institutes / Universities / Biotech & Pharma / Veterinary and Food Laboratories

Amount of employees: 280

BioNordika Group consists of: BioNordika Sweden AB, BioNordika Denmark A/S, BioNordika Finland OY, BioNordika Norway AS. Sales of laboratory equipment and reagents mainly for research

Geographical market: Sweden, Denmark, Norway, Finland, Estonia

Segment: Cell & Molecular Biology, immunology for academic research and pharma industry, as well as laboratory equipment

Customer examples: AstraZeneca, Karolinska Institute, Novo Nordisk, Novozymes, Institute for Molecular Medicine Finland

Amount of employees: 36

Supplier and manufacturer of a wide range of laboratory equipment and reagents.

Geographical market: Italy

Segment: Cell Biology, Molecular Biology, NGS, Immunology, Lab Equipment, Plasticware, HighTech Instrument and Medical Devices for the Life Science and Healthcare sector.

Customer examples: University research centres , Private research centres, Private and Public Hospital, Pharmaceutical Company, Industrial Company and Diagnostic Laboratories

Amount of employees: 58

Sales of laboratory equipment and service to research, industry and universities

Geographical market: Denmark

Segment: Wide range of laboratory products for Life Science, -80 Freezers, Laminar Air Flow cabinets

Customer examples: Novo Nordisk, Novozymes, LeoPharma, University of Copenhagen

Amount of employees: 44

Sales of diagnostic instruments and reagents to customers in the public healthcare and academic research

Geographical market: Finland, Sweden, Norway, Denmark, Estonia

Segment: Molecular diagnostics, 3D bioprinting, microbiology, pathology, genetics, cell biology, microscopy & imaging

Customer examples: HUSLAB, The Hospital District of Helsinki and Uusimaa, Oulu University Hospital

Amount of employees: 37

Production and sales of equipment for microbiological analyses to laboratories within the food industry

Geographical market: Mainly Europe and Northern America

Segment: Food microbiology

Customer examples: Eurofins, Synlab

Amount of employees: 12

Lab-Vent Controls A/S manufactures and installs control systems and alarms for ventilation systems in laboratories and operating rooms.

Geographical market: Denmark

Segment: Specialized ventilation solutions for laboratories and clean rooms with high demands on controlling air flows

Customer examples: University of Copenhagen, Aarhus University Hospital, University of Aarhus, Novo Nordisk, Rigshospitalet, Niels Bohr Institute

Amount of employees: 20

Triolab Group consists of: Triolab AB (Sweden), Triolab A/S (Denmark), Triolab OY (Finland), Triolab Baltic Oü (Estonia, Lithuania and Lativa), Bergman Diagnostika AS (Norway). Sales of diagnostic instruments and reagents

Geographical market: Sweden, Denmark, Norway, Finland, Estonia, Lithuania, Latvia

Segment: Blood gas, clinical chemistry, microbiology, molecular biology, immunology, pathology, hematology, POC and veterinary for customers in public sector and private sector medical care, as well as the pharmaceutical industry.

Customer examples: Karolinska University Hospital, Sahlgrenska Hospital, Odense University Hospital, Novo Nordisk, HUSLAB, Helsinki and Uusimaa Hospital District, Norwegian Health Care, Rikshospitalet, Haukeland University Hospital, St. Olavs Hospital

Amount of employees: 137